CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- 4 Grant or award Director acquired 5,250 shares (grant or award)
- 4 Grant or award Director acquired 5,250 shares (grant or award)
- 8-K Event Shareholder vote results
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 3 Insider Initial Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Executive or director change · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award SVP, Chief Business Officer acquired 25,000 shares (grant or award)
- 4 Grant or award SVP Finance, CFO acquired 34,500 shares (grant or award)
- 4 Grant or award SVP Clinical Development, CMO acquired 34,500 shares (grant or award)
- 4 Grant or award SVP of Research, CSO acquired 34,500 shares (grant or award)
Page 17 of 34 · 678 filings